Falk Bechara
SESSIONS
F046 HS Surgery from Start to Finish: Planning, Procedures, and Post-op Care
Mar 9, 2024
•
9:00 AM - 11:00 AM
•
Room 1B
S026 Late-breaking Research: Session 1
Mar 9, 2024
•
9:00 AM - 12:00 PM
•
Room 20B
HANDOUTS
Login to view handouts
DISCLOSURES
AbbVie – Advisory Board(Fees); Acelyrin – Other(Fees); Boehringer Ingelheim – Other(Fees); Celltrion – Advisory Board(Fees); Dr. August Wolff GmbH& Co. – Advisory Board(Fees); Incyte – Other(Fees); Janssen-Cilag – Speaker(Fees); Mölnlycke – Other(Fees); MoonLake Immunotherapeutics – Advisory Board(Fees); Novartis – Speaker(Fees); UCB Pharma – Speaker(Fees);